217.2: A Multi-institutional Study of Factors Determining Cardiac Allograft Function in Children at 3 Years Post-transplant: Absence of Impact of Donor Specific Antibodies

Autor: Steven A. Webber, Hyunsook Chin, Brian Armstrong, Charles E Canter, Anne I Dipchand, Debra A Dodd, Brian Feingold, Jacqueline Lamour, William Mahle, Joseph W Rossano, Tajinder P Singh, Warren A Zuckerman, Yvonne Morrison, Helena Diop, Carol Bentlejewski, Jonah Odim, Adriana Zeevi, James Wilkinson

Publikováno v: Transplantation. 106:S61-S61

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::46ec72ce83b9b9dc1bc70deede1597db
https://doi.org/10.1097/01.tp.0000885564.92568.09

Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes

Autor: Nancy D. Bridges, Kenneth A. Newell, Madhav C. Menon, Girish N. Nadkarni, Jens Goebel, Barbara Murphy, Peter Nickerson, Emilio D. Poggio, Richard N. Formica, Yvonne Morrison, Geovani Faddoul, David N. Rush, Donald E. Hricik, Peter S. Heeger

Publikováno v: Transplantation. 102:673-680

Background An early posttransplant biomarker/surrogate marker for kidney allograft loss has the potential to guide targeted interventions. Previously published findings, including results from the Clinical Trials in Organ Transplantation (CTOT)-01 st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0901e6f4ab0bbbb1069de1476804c7e6
https://doi.org/10.1097/tp.0000000000002026

Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation

Autor: Randall C. Starling, Brian Armstrong, Nancy D. Bridges, Howard Eisen, Michael M. Givertz, Abdallah G. Kfoury, Jon Kobashigawa, David Ikle, Yvonne Morrison, Sean Pinney, Josef Stehlik, Sudipta Tripathi, Mohamed H. Sayegh, Anil Chandraker, Barbara Gus, Karen Keslar, Bill Magyar, John Petrich, W. H. Wilson Tang, Kimberly Brooks, Michael Givertz, Charles Kelly, Katie Klein, Kerry Crisalli, Sandra DeBronkart, Joren Madsen, Marc Semigran, John Vetrano, Teresa DeMarco, Scott Fields, Carol Maguire, Robert Gordon, Allen Anderson, Jane Regalado, Anna Warzecha, Lee Goldberg, Caroline Olt, Kenneth Rockwell, Ashley Harris, Maryl Johnson, Susan Johnston, Chris Roginski, Rashid Ahmed, Ivy Cohen, Denise Peace, Tina Yao, Gloria Araujo, Arvind Bhimaraj, Eunice Karanga, Varsha Patel, Julie Chait, Mario Deng, Gregg Fonarow, Christina Shin, Charles Gibbs, Judson Hunt, Melissa Johnson, Tina Worley, Jeff Gibbs, John Kirk, Winter Redd, Julia Bryan, Anna French, A.G. Kfoury, Kristin Konery, Erika Feller, Myounghee Lee, Richard Pierson, Cindi Young, Theodora Hollifield, Kimberley Porter, Mariann Schulz, Adrian VanBakel, Kiran Khush, Helen Luikart, Son Nguyen, Michael Pham, David DeNofrio, Ryan O’Kelly, Lucilla Garcia, Sean Sana, Brandy Starks, Maria Thottam, Annie Yi, Barry Cabuay, Rachel Olson, Larry Tucker, Laura Uppgaard, Denise Lai, Colleen Poisker, Klaudija Dragicevic, Harrison Kelner, Darlette Luke, Jennifer Nelson, Ganesh Raveendran, Nick Kleissas, Srinivas Murali, Kenneth Rayl, Sarah Sherry, Michele Cosgrove

Publikováno v: Journal of the American College of Cardiology. 74(1)

Background The CTOT-11 (Prevention of Cardiac Allograft Vasculopathy Using Rituximab Therapy in Cardiac Transplantation [Clinical Trials in Organ Transplantation-11]) study was a randomized, placebo-controlled, multicenter, double-blinded clinical tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce37b32e10cc5b2e2a85c6e16247b9e0
https://pubmed.ncbi.nlm.nih.gov/31272551

Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18

Autor: Sean Pinney, Judson Hunt, Anil Chandraker, Michael M. Givertz, Teresa De Marco, David A. Baran, Joren C. Madsen, Robert J. Gordon, Sudipta Tripathi, David Ikle, Josef Stehlik, Nancy D. Bridges, Randall C. Starling, Erika D. Feller, Yvonne Morrison, Alain Heroux, Brian Armstrong, Peter S. Heeger, Abdallah G. Kfoury

Publikováno v: Am J Transplant

Clinical Trials in Organ Transplantation-18 (CTOT-18) is a follow-up analysis of the 200-subject multicenter heart transplant CTOT-05 cohort. CTOT-18 aimed to identify clinical, epidemiologic, and biologic markers associated with adverse clinical eve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::961a1c6503b9c3f1a34fad0344bd1c65
https://pubmed.ncbi.nlm.nih.gov/30549425

Incidence, characterization, and impact of newly detected donor-specific anti-HLA antibody in the first year after pediatric heart transplantation: A report from the CTOTC-04 study

Autor: David Ikle, Jonah Odim, Anne I. Dipchand, Yvonne Morrison, A. Zeevi, Brian Armstrong, S. Webber, Brian Feingold, Elizabeth D. Blume, Helena Diop, William T. Mahle, Robert E. Shaddy, Charles E. Canter, W. Zuckerman, Kristen L Mason, Carol Bentlejewski, Jacqueline M. Lamour

Publikováno v: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 18(9)

Data on the clinical importance of newly detected donor-specific anti-HLA antibodies (ndDSAs) after pediatric heart transplantation are lacking despite mounting evidence of the detrimental effect of de novo DSAs in solid organ transplantation. We pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::479a1f84e3443369f068e5ab34f61caa
https://pubmed.ncbi.nlm.nih.gov/29947127